ArticleMolecular oncology2024

Dual targeting of the androgen receptor and PI3K/AKT/mTOR pathways in prostate cancer models improves antitumor efficacy and promotes cell apoptosis.

Tatsuo Sugawara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.